489 related articles for article (PubMed ID: 24447114)
21. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
[TBL] [Abstract][Full Text] [Related]
22. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
23. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
24. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment.
Bilò MB
Allergy; 2011 Jul; 66 Suppl 95():35-7. PubMed ID: 21668850
[TBL] [Abstract][Full Text] [Related]
25. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
27. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly.
Guenova E; Volz T; Eichner M; Hoetzenecker W; Caroli U; Griesinger G; Burow G; Mitev V; Biedermann T
Allergy; 2010 Jul; 65(7):919-23. PubMed ID: 20121769
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
[TBL] [Abstract][Full Text] [Related]
29. When can immunotherapy for insect sting allergy be stopped?
Müller UR; Ring J
J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
[TBL] [Abstract][Full Text] [Related]
30. Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.
White KM; England RW
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):426-30. PubMed ID: 18939733
[TBL] [Abstract][Full Text] [Related]
31. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
32. Natural history and long-term follow-up of Hymenoptera allergy.
Ruëff F
Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):445-451. PubMed ID: 32739977
[TBL] [Abstract][Full Text] [Related]
33. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema.
Stoevesandt J; Hain J; Kerstan A; Trautmann A
J Allergy Clin Immunol; 2012 Sep; 130(3):698-704.e1. PubMed ID: 22554708
[TBL] [Abstract][Full Text] [Related]
34. [New variants of diagnostic procedures and therapeutic methods in insect venom allergy].
Nittner-Marszalska M
Pol Merkur Lekarski; 2003 Jun; 14(84):700-2. PubMed ID: 14524309
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Hymenoptera venom allergy: an update.
Pesek RD; Lockey RF
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):340-6. PubMed ID: 24887986
[TBL] [Abstract][Full Text] [Related]
36. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
37. Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis.
Michel J; Brockow K; Darsow U; Ring J; Schmidt-Weber CB; Grunwald T; Blank S; Ollert M
Allergy; 2016 May; 71(5):651-60. PubMed ID: 26836051
[TBL] [Abstract][Full Text] [Related]
38. Two cases of elevated tryptase in abdominal aortic aneurysm.
Pastorello EA; Schroeder JW; Veronese SM; Pravettoni V; De Gasperi A; Cantoni S; Losappio L; Farioli L; Qualizza R; Scarpati B; Mascheri A; Scibilia J
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):58-61. PubMed ID: 25781196
[TBL] [Abstract][Full Text] [Related]
39. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
[TBL] [Abstract][Full Text] [Related]
40. Venom immunotherapy: clinical efficacy, safety and contraindications.
Kosnik M; Korosec P
Expert Rev Clin Immunol; 2015; 11(8):877-84. PubMed ID: 26018865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
